HOME >> MEDICINE >> NEWS
OHSU vaccine and gene therapy institute receives $3.5 million for AIDS vaccine research

PORTLAND, Ore. Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS. Louis Picker, M.D., associate director of the VGTI and director of the institute's vaccine program, will serve as principal investigator of the five-year study. The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, is funding this research.

The research team is hoping to develop a new class of viral vaccine vectors to serve as the basis of HIV vaccine. Vectors are modified viruses used to safely deliver proteins from a disease-causing virus to the body. Vectors infect individuals, but do not cause any disease themselves. Rather, they serve to present the proteins from a disease-causing virus to the vaccinated person's immune system. This presentation allows the system to generate an immune response capable of protecting the vaccinated person from subsequent encounters with the disease-causing virus.

Most of the HIV vaccine development to date has focused on weakened viral vectors designed to infect the vaccinated person only briefly, insuring that the vector itself does not persist and potentially cause problems. For example, current approaches for HIV vaccines include weakened versions of the smallpox vaccine virus (vaccinia) or adenovirus engineered to produce HIV proteins. Both of these vectors can only survive for a limited time in the human body before they are eliminated by the immune system. While these vectors can generate high anti-HIV immune responses immediately following vaccination, these responses decline with time and may not produce an immune response of the correct characteristics to contain a chronic aggressive virus like HIV
'"/>

Contact: Jim Newman
newmanj@ohsu.edu
503 494-8231
Oregon Health & Science University
25-May-2004


Page: 1 2 3

Related medicine news :

1. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
2. NIAID initiates trial of experimental avian flu vaccine
3. Study finds majority of women willing to accept cervical cancer vaccine for self and children
4. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
5. Earlier use of prostate cancer vaccines urged by Hopkins scientists
6. Researchers close in on breast cancer vaccine
7. EuroVacc 02 HIV vaccine trial begins in February 2005
8. Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
9. Pathogen-mimicking vaccine as strategy for cancer therapy
10. HIV vaccine trial breaks ground for future research
11. First US kidney cancer vaccine trial underway at Columbia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 31, 2020 , ... Today Hinge Health, ... expansion of clinical & technical capabilities to cover the full continuum of care ... joint health solution. , Currently, employers interested in truly solving their MSK ...
(Date:7/22/2020)... ... , ... Ocean Tomo Transactions, LLC will auction a patent ... Brock University for jurisdictions throughout North America, Europe and Asia. Ocean Tomo ... manufacturing processes of novel opioid related compositions for pain management as well as ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... “Frozen.” It’s ... to a shoulder joint – oftentimes for unknown reasons – resulting in stiffness, persistent ... MD , an expert in treating problems of the upper limbs and joints and ...
(Date:7/18/2020)... ... July 18, 2020 , ... When the federal government extended ... opportunity for small and some bigger businesses to obtain a PPP loan. But the ... the “GIG Economy” do not realize they are eligible. , While 4.9 million ...
(Date:7/10/2020)... ... July 09, 2020 , ... CellTrak, ... behavioral health announces that Ohio Department of Medicaid has awarded CellTrak Phase 2 ... agencies in Ohio already rely on CellTrak for EVV – both as a ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... July 10, 2020 , ... The Dolphin Company, the ... more than 12 million guests, unveiled its new comprehensive plan of protocols and ... in all facets of the operation, safety, and health addressing COVID-19. , Experts ...
(Date:7/10/2020)... FRANCISCO, Calif. (PRWEB) , ... ... ... Pharmaceutical Review , the leading review of business and technology for the ... cover the development and manufacturing of the highest quality pharmaceutical products. ...
(Date:7/7/2020)... ... July 07, 2020 , ... To support those on the ... Change (WGC), will be providing meals to the employees of Southern Nevada Health District. ... throughout Las Vegas on Wednesday, July 8th. , When asked why the Women of ...
Breaking Medicine Technology:
Cached News: